Colonis Pharma, is delighted to announce its new collaboration with Movianto, a leading supply chain solutions partner, to optimize its logistics services for the UK market. The partnership commenced on 1st March, 2024.
As a key player in pharmaceutical and healthcare logistics, Movianto offers best-in-class quality, ensuring seamless supply chain management for the delivery of pharmaceutical products. By leveraging Movianto’s expertise, Colonis Pharma aims to enhance its supply chain and guarantee a consistent and reliable supply of its value-added medicines to patients across the UK.
This strategic alliance marks another significant milestone for Colonis Pharma, reinforcing its commitment to the well-being of patients. By entrusting Movianto with their logistics operations, Colonis Pharma can focus on its core mission of developing value-added medicines to meet patients unmet clinical needs.
“We are delighted to embark on this partnership with Movianto,” said Penny Ralph, Head of Supply Chain at Colonis Pharma. “Their exceptional logistics services will enable us to streamline our supply chain, ensuring uninterrupted access to our vital medicines for the patients who rely on them. This collaboration aligns with our vision to provide high-quality healthcare solutions and make a positive impact on the lives of individuals throughout the UK.”
Movianto’s extensive experience in supply chain management, coupled with Colonis Pharma’s commitment to excellence, represents an important step forward in fulfilling Colonis Pharma’s mission to bring value added medicines to the UK market.
“The aim of our fully integrated Order to Cash service, is really to free manufacturers to do what they do best. We are proud to be working with Colonis Pharma, knowing that we will be delivering vital medicines, and allowing Colonis Pharma to place further efforts into identifying and fulfilling unmet clinical needs.
Welcome to the Movianto network Colonis Pharma.” – Christina Morrissey – Order To Cash Business Unit Manager.
GB-CPL-0-068
February 2024
